10.27.26 -- The 5 Shifts That Could Remake Lyophilization By 2040

UV-protective single-use bags address a specific vulnerability in biopharmaceutical manufacturing, where UV exposure during production, storage, and cold chain logistics can compromise sensitive products.

Discover insights into how innovative connectors streamline workflows, save time, and enhance reliability in critical applications, ultimately supporting improved outcomes in cell and gene therapies.

See how tiered automation platforms resolve cell therapy manufacturing bottlenecks, enabling a seamless transition from clinical trials to high-volume commercial supply.

Automated fill-finish systems protect sensitive cell therapies using low-shear handling to maintain dose uniformity, cell viability, and process consistency across every batch.

Comparing isolator decontamination cycle times requires evaluating key variables like aeration endpoints and load patterns to build accurate capacity models and avoid costly delays.

Non-PEG stabilizer lipids may offer a new path for LNP design. Combining strong colloidal performance with greater chemical flexibility helps address growing concerns around PEG-related immunogenicity.

Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization. 

Targeted optimization of cell culture media and transfection reagents increased AAV titers ninefold while improving full capsid percentages, strengthening HEK293 production, and more.

Sensitive digital PCR methods enable confident detection of low‑abundance iPSC markers. Gain insight into how these capabilities support more reliable monitoring and quality assessment.

Successful viral vector scale‑up depends on early process design, predictive models, and execution strategies that anticipate GMP realities rather than simply increasing production volume.

Gain practical insights into the manufacturing realities shaping in vivo CAR-T development and watch how leading teams are addressing the challenges of scaling both LNP and viral vector platforms.

Examine two rapid, high‑throughput strategies for small‑scale protein separation, using either multimodal resins or ion exchange membranes to achieve efficient, low‑volume purification.

Discover how low-shear centrifugation improves lentiviral vector recovery by replacing traditional depth filtration with closed, automated systems that preserve yield and reduce waste and production costs.

Learn about a feeder-free method to differentiate CD8+ single positive T cells from human induced pluripotent stem cells, which offers promising advancements for scalable and efficient cell therapies.

Explore various strategies to enhance viral titer and increase the percentage of full AAV capsids, like modifications to transfection reagents, cell lines, media, procedures, and more.

Manufacturing operations are getting a boost thanks to single-use technologies, but how do biopharmaceutical manufacturers choose the right materials for constructing their single-use solutions?